Vertex Pharmaceuticals Inc. (stock symbol: VRTX) is a publicly traded company listed on US, operating within the PHARMA sector. As of the latest trading session, Vertex Pharmaceuticals Inc. is trading at $482.49 with a market capitalization of 125.00B. The stock has experienced a decline of 0.58% in today's trading, reflecting bearish sentiment among market participants.
The day's trading range has been between $477.57 (low) and $489.87 (high), with an opening price of $484.09 compared to the previous close of $485.30. Approximately 10.30M shares have changed hands, indicating strong liquidity and active investor interest in this stock.
Key Market Metrics for VRTX:
Investors tracking VRTX should note that the P/E ratio of 27.50 indicates moderate market expectations for future growth. Understanding these fundamental metrics alongside technical price action gives investors a comprehensive view of Vertex Pharmaceuticals Inc.'s market position and future prospects on US.
The PHARMA sector has been an area of consistent interest for market participants. Companies within this sector demonstrate varying performance based on macroeconomic factors, regulatory changes, and company-specific developments. Vertex Pharmaceuticals Inc. continues to adapt to market dynamics while maintaining its competitive positioning.
For technical analysis, traders monitor several key levels for VRTX: support at $477.57 and $485.30, and resistance at $489.87. The P/E ratio of 27.50 provides valuation context, helping investors determine if Vertex Pharmaceuticals Inc. is trading at a premium or discount relative to its earnings potential. Regular monitoring of quarterly results, management commentary, and sector-wide trends will help investors stay informed about VRTX's trajectory on US.
The current live price of Vertex Pharmaceuticals Inc. (VRTX) is $482.49 as of the most recent market data update on US. This price reflects the last traded value and changes in real-time during market hours. Today's trading session opened at $484.09, compared to the previous day's close of $485.30.
The intraday price action for VRTX shows a high of $489.87 and a low of $477.57, giving the stock a daily trading range of approximately $12.30. The stock has experienced a decline of 0.58% in today's session. The total volume traded stands at approximately 10.30M shares.
Key Market Metrics for VRTX:
Market participants tracking VRTX should note that these prices are live and updated from market data providers. The market cap of 125.00B places Vertex Pharmaceuticals Inc. among significant companies listed on US. Trading volume of 10.30M shares suggests strong liquidity and active investor interest in this stock.
Understanding the price history of Vertex Pharmaceuticals Inc. (VRTX) is essential for both technical and fundamental analysis. The stock's current price of $482.49 can be better understood in the context of its recent trading patterns and long-term trends on US.
Today's price action shows VRTX opening at $484.09 compared to the previous close of $485.30. The intraday high of $489.87 and low of $477.57 represent the price boundaries for today's trading session. The negative movement of 0.58% provides insight into the day's market sentiment toward Vertex Pharmaceuticals Inc..
For technical analysis, traders monitor several key levels for VRTX:
The P/E ratio of 27.50 provides a valuation benchmark comparing Vertex Pharmaceuticals Inc.'s stock price to its earnings per share. These fundamental metrics, combined with technical price action, give investors a comprehensive view of VRTX's current market position and future prospects on US.
Investors are advised to use the interactive chart above to analyze VRTX's price trends across different timeframes — from intraday 1D charts for short-term traders to 1Y charts for long-term investors. The combination of fundamental analysis and technical chart patterns helps in making well-informed decisions about Vertex Pharmaceuticals Inc. stock in the PHARMA sector.
Indian investors looking to purchase Vertex Pharmaceuticals Inc. (VRTX) shares have several reliable options through registered stockbrokers and trading platforms. The process of buying VRTX shares in India involves opening a demat and trading account with a SEBI-registered broker, completing the KYC (Know Your Customer) process, and funding the account to start trading. Below are the most popular platforms for investing in VRTX and other stocks on US.
Zerodha is India's largest retail stockbroker by active clients and offers a seamless platform for buying VRTX shares. With Zerodha's Kite platform, you can trade Vertex Pharmaceuticals Inc. stocks on NSE and BSE with zero brokerage on equity delivery trades. The account opening process is fully digital and can be completed in minutes. Open a Zerodha account here to start investing in VRTX with zero brokerage on delivery trades and flat €20 per trade on intraday and F&O.
Groww offers an intuitive mobile-first investment platform that is perfect for beginners looking to buy Vertex Pharmaceuticals Inc. shares. With a simple interface and educational resources, Groww makes it easy to invest in VRTX and thousands of other stocks and mutual funds. The platform offers zero account opening fees and zero brokerage on equity delivery. Sign up on Groww to begin your investment journey with Vertex Pharmaceuticals Inc. shares.
Angel One is another excellent choice for trading VRTX stocks, offering advanced charting tools, research reports, and expert recommendations. The platform provides free equity delivery trades and a powerful mobile trading app. Angel One's research team publishes regular analysis on Vertex Pharmaceuticals Inc. and other PHARMA sector stocks to help you make informed decisions. Open an Angel One account and get access to expert stock recommendations and advanced trading tools.
Steps to Buy VRTX Shares in India: